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Abstract: There are various theories concerning the etiology of preeclampsia and
eclampsia. According to one of these, the
immunologic mechanism may play a role.
The aim of this study was to determine
whether or not T and B Iymphocytes and
NK cells, which are important in cellular
immunity, play a role in the development
of this disease. We determined the percentage of the subgroups CD2, CD4 and
CD8 of the T Iymphocytes, CD20 of the B
Iymphocytes and CD56 of the NK cells in
26 preeclamptic pregnant women in their
3rd trimestir. All of these elements were
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Introduction
Usually, eclampsia is seen during the first pregnancy, but it may be seen in multiuparity in multiparity in cases of twins or diabetes, chronic hypertension, renal disease, etc. In teh U. S. A., studies
have shown that 5% of pregnant women are preeclamptic and of these, 10% develop eclampsia (1).
The etiology of disease is as yet not completely
konwn. Various theories have been proposed. One of
these theories suggests that an immune mechanism
plays a part in the theories suggests that an immune
mechanism plays a part in the etiology (2). Even
though there has been little research done on this,
some studies have found the levels of serum complement to be normal, a decrease in the fnctional activities of the NK cells, and an increase in the serum levels of IgE, antinuclear antibodies (ANA), and
antimitochondrial antibodies (AMA) (3-8). In another
study, especially CD-4 carrying helper-ınducer T cels
were found to be elevated, resulting in an altered CD4/CD-8 ratio (9). In order to establish whether these
components of cellular immunity play a part in the development of eclampsia, we determined the percentages of cells that are active in the immune response. These included the pan-T (CD2) of the T

olso investiğated in 13 normal pregnant
women. The statistical evaluations were
done with the student-t-test. Only the differences in percentages of the CD2 and
CD56 cells between the preeclamptic pregnant women and the normal pregnant
women were found to be statistically significant (p < 0.01 and < 0.001, respectively). It was concluded that significantly decreased NK cells can be blamed
in the pathomechanism of preeclampsia.
Key Words: Preeclampsia, T Iymphocytes, B
Iympocytes, NK cells

Iymphocytes, the T-helper (DD4) and T-suppressor
(CD8) of the subgroups of T Iymphocytes, pan-B
(CD20) of the B Iymphocytes, and NK cells (CD56)
Materials and Methods
This study was carried out on the venous blood of
26 preeclamptic pregnant women and 13 normal
pregnant women. The Epic-profile I Coulter flow cytometry (Epics Division of Coulter Corporation, P. O.
BOX 169015, MİAMİ, Florida 33116-9015, USA) was
used to determine the percentages of the pan-T
(CD2), T-helper (CD4) and T suppressor(CD8) of the
T-Iymphocyte subgroups and pan-B (CD20) of the B
Iymphocytes as well as the NK cells (CD56) from the
preeclamptic and normal pregnant women. For this
purpose 1 cc of venous blood was taken from each
patient and control and added to a tube containing
ethyl diamene tetra acetic salt (EDTA). For each type
of cells, 100 µl blood was placed into a 12x75 mm
test tube and 10 µl of a suitable monoclonal antibody
solution was added. The following monoclonal antibody
solution was added. The following monoclonal antibodies were used in this study : T11-RD1/B1-FITC
(Coulter code-2524R133), T4-RD11/T8-FITC (Coulter
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code-2224E243),
2933J103).

and

NKH-1-RD1

(Coulter

code-

weeks. The ranges of all of the results from the two
groups are shown in Table 1.

The samples were incubated for10 minutes at
room temperature. Later, after the samples were
placed in the Coulter Multi-Q-Prep instrument, 600 µl
of immunoprep A (Erythrocyte Lytic Agent), 265 µl of
immunoprep B (leukocyte stabilizer) and 100 µl of immunoprep C (cell membrane fixative) were added.
Then the preparations were transferred one by one to
the flow cytometry instrument and the percentageös
of all of the parameters were determined.

When the data obtained from two groups were
compared, it was found that only teh CD2 and CD56
results were statistically significant (p< 0.01 and <
0.001, respectively). There were no stitistically significant differences between the remaining results
(CD4, CD8, CD20, CD4/CD8) of the two groups
(p>0.05; Table 1).

Statistical evaluation was performed with studen’s t
test, and all values were expressed as the mean ± SD
(CSS; Complete Statistical System).
Results
In this study certain variables were e valuated in
26 preeclamptic and 13 normala pregnant women.
The average age of the preeclamptic pregnant women
was 26.6 ± 5.7 years, their bood pressure was 146.1
± 16.9/95.3 ± 8.6 mmHg and their duration o1f
pregnancy was 34.7 ± 4.7 weeks. When the blood
pressure in the two groups was compared, a statistically significant difference was obtained only from
the systolic blood pressure (p<0.001). The average
age of the normal pregnant women was 28 ± 4.7
years, their blood pressurewas 120±9.1/77.6±4.3
mmHg and the duration of pregnancy was 33.6 ± 4.9

Table 1.

Discussion
A review of the literature concerned with preeclampsia and eclampsia reveals that the etiology is
not quite clear and that the immunologic mechanism is
thought to play an important role in the etiopathology
(2). Studies which have been done in this field have
found that the serum levels of complement are normal
and the level of serum IgE, high. While antinuclear antibody (ANA) and antimitochondrial antibody (AMA)
may be found occasionally, the rate of smooth muscle
antibody (SMA) detected is higher than normal (4,6).
Besides this, studies, which have been done on preeclamptic patients concerning cell immunity, have
shown that the velocity of Iymphocyte transforkation
in these patients is slow and that the immune activity
is decreased. It has been shown that there is a immunological conformity between mother and child. It
has been suggested that this low immune response is
compatible with the etiological characteristics of pre-

Average values in preeclamptic/eclamptic pregnant women and normal pregnant women
n

Blood

Age

Week of

CD2%x

CD4 %x

CD8 %x

CD4/CD8x

CD20 %

NK %x

*PPW

26

146.1±16.9/
95.3±8.6

26.6±5.7

34.7±4.7

83.6±4.8

41.1±9.2

26.4±6.8

1.6±0.5

10.4±3.8

7.6±3.5

**NPW

13

120±9.1/
77.6±4.3

28.0±4.7

33.6±4.9

77.4±7.0

44.3±6.5

23.5±6.4

1.9±0.5

10.3±3.0

13.4±5.4

<0.001

>0.05

>0.05

<0.01

>0.05

>0.05

>0.05

>0.05

<0.001

P value

*Preeclamptic pregnant women
** Normal pregnant women

eclampsia ad, also, that the low immune response is
related to disturbances in other systems (6,11). In
most of the studies on preeclamptic patients, it has
been found that there is a lowering of the functional
activities of the natural killer (NK) cells (3, 7, 8). In
only one study, it was found that there was an in-
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crease in the activities of the NK cells of these patiens
in comparison to those of normal pregnant women
(10). In another study, it was shown that the disturbance of cellular immunity during pregnancy is not
related to Iymphocytes (CD4 or OK T4) which produce IL-2. Other studies havğ shown that the retes of
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CD4 in preeclamptic patients begin to decrease in early
stages of pregnancy before the occurrence of preeclampsia and that the normal levels are only reached
several weeks after birth (13,14). In another study, it
was also found that the rates of CD/CD8 in these patients in comparison to normal pregnant women were
lower (15). In a study of Bettin, an elevated number
of T Iymphocytes, especially of CD-4 carrying helperinducer T cells, was determined, resulting in an altered
CD-4/CD-8 (9); we have also determined significantly
increased number of T Iymphocytes in preeclampsia,
but CD-8 elevation instead of CD-4 contributed to this
increase in T Iymphocytes.
In our study, we found the percentages of NK cells
to be lower in preeclamptic pregnant women than in
normal pregnant women (7.6 ± 3.5, 13.4 ± 5.4, respectively) and that there was a stitistically significant
difference between them (p < 0.001). At the same

time, in our study, the rate of CD2 of the subgroups
of Iymphocytes in preeclamptic pregnant women was
found to be higner as compared to that of normal
pregnant women; we found that when this parameter
was compared in the 2 groups, there was a statistically significant difference (p < 0.01). On the other
hand, there was no statistical difference between the
rates of CD4, CD8, CD20 and CD4/CD8 in preclamptic
pregnant women and normal pregnant women.
In some studies, a participation of macrophages in
the pathomechanism of preeclampsia has also been assumed (9,16); in the present study, we have not performed an analysis demonstrating teh effect o1 macrophages or neutrophils on preeclampsia.
When our results are evaluated with those in the
literature, it’s possible to conclude that significantly decreased NK cells can be blamed in the pathomechanism
of preeclampsia.
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